IL6 and cancer: Moreover, the E3 ubiquitin ligase NEDD4L interacts with GP130, promoting its ubiquitination in tumors and thwarting the activation of the IL-6/GP130/STAT3 signaling axis, thereby exhibiting anti-cancer properties (29).